Free Access
Med Sci (Paris)
Volume 26, Number 2, Février 2010
Page(s) 159 - 164
Section M/S revues
Published online 15 February 2010
  1. Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983; 220 : 868–71. [Google Scholar]
  2. Medzhitov R, Littman D. HIV immunology needs a new direction. Nature 2008; 455 : 591. [Google Scholar]
  3. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS clinical trials group 320 study team. N Engl J Med 1997; 337 : 725–33. [Google Scholar]
  4. Perelson AS, Essunger P, Cao Y, et al. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 1997; 387 : 188–91. [Google Scholar]
  5. Chun TW, Finzi D, Margolick J, et al. In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. Nat Med 1995; 1 : 1284–90. [Google Scholar]
  6. Piatak M Jr, Saag MS, Yang LC, et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993; 259 : 1749–54. [Google Scholar]
  7. Chun TW, Carruth L, Finzi D, et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997; 387 : 183–8. [Google Scholar]
  8. Finzi D, Hermankova M, Pierson T, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997; 278 : 1295–300. [Google Scholar]
  9. Wong JK, Hezareh M, Gunthard HF, et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997; 278 : 1291–5. [Google Scholar]
  10. Bailey JR, Sedaghat AR, Kieffer T, et al. Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells. J Virol 2006; 80 : 6441–57. [Google Scholar]
  11. Barber SA, Gama L, Dudaronek JM, et al. Mechanism for the establishment of transcriptional HIV latency in the brain in a simian immunodeficiency virus-macaque model. J Infect Dis 2006; 193 : 963–70. [Google Scholar]
  12. Keele BF, Tazi L, Gartner S, et al. Characterization of the follicular dendritic cell reservoir of human immunodeficiency virus type 1. J Virol 2008; 82 : 5548–61. [Google Scholar]
  13. Zack JA, Arrigo SJ, Weitsman SR, et al. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 1990; 61 : 213–22. [Google Scholar]
  14. Haase AT, Henry K, Zupancic M, et al. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 1996; 274 : 985–9. [Google Scholar]
  15. Stevenson M, Stanwick TL, Dempsey MP, Lamonica CA. HIV-1 replication is controlled at the level of T cell activation and proviral integration. Embo J 1990; 9 : 1551–60. [Google Scholar]
  16. Han Y, Lassen K, Monie D, et al. Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes. J Virol 2004; 78 : 6122–33. [Google Scholar]
  17. Lassen K, Han Y, Zhou Y, et al. The multifactorial nature of HIV-1 latency. Trends Mol Med 2004; 10 : 525–31. [Google Scholar]
  18. Lenasi T, Contreras X, Peterlin BM. Transcriptional interference antagonizes proviral gene expression to promote HIV latency. Cell Host Microbe 2008; 4 : 123–33. [Google Scholar]
  19. Van Lint C. Role of chromatin in HIV-1 transcriptional regulation. Adv Pharmacol 2000; 48 : 121–60. [Google Scholar]
  20. Wurtele H, Li Q, Zhou H, et al. L’acétylation des histones : un nouveau maillon de la chaîne d’assemblage du nucléosome. Med Sci (Paris) 2009; 25 : 121–2. [Google Scholar]
  21. Peterson CL, Laniel MA. Histones and histone modifications. Curr Biol 2004; 14 : R546–51. [Google Scholar]
  22. Williams SA, Greene WC. Regulation of HIV-1 latency by T-cell activation. Cytokine 2007; 39 : 63–74. [Google Scholar]
  23. Du Chene I, Basyuk E, Lin YL, et al. Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency. Embo J 2007; 26 : 424–35. [Google Scholar]
  24. Marban C, Suzanne S, Dequiedt F, et al. Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing. Embo J 2007; 26 : 412–23. [Google Scholar]
  25. Rohr O, Lecestre D, Chasserot-Golaz S, et al. Recruitment of Tat to heterochromatin protein HP1 via interaction with CTIP2 inhibits human immunodeficiency virus type 1 replication in microglial cells. J Virol 2003; 77 : 5415–27. [Google Scholar]
  26. Li B, Carey M, Workman JL. The role of chromatin during transcription. Cell 2007; 128 : 707–19. [Google Scholar]
  27. Nelson DE, Ihekwaba AE, Elliott M, et al. Oscillations in NF-kappaB signaling control the dynamics of gene expression. Science 2004; 306 : 704–8. [Google Scholar]
  28. Weinberger LS, Burnett JC, Toettcher JE, et al. Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity. Cell 2005; 122 : 169–82. [Google Scholar]
  29. Weinberger LS, Dar RD, Simpson ML. Transient-mediated fate determination in a transcriptional circuit of HIV. Nat Genet 2008; 40 : 466–70. [Google Scholar]
  30. Pearson R, Kim YK, Hokello J, et al. Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency. J Virol 2008; 82 : 12291–303. [Google Scholar]
  31. Bertin A, Mangenot S. Structure et dynamique de la particule cœur du nucléosome. Med Sci (Paris) 2008; 24 : 715–9. [Google Scholar]
  32. Estaquier J, Hurtrel B. Sanctuaire du virus de l’immunodéficience humaine et mécanismes d’échappement. Med Sci (Paris) 2008; 24 : 1055–60. [Google Scholar]
  33. Ray-Gallet D, Gérard A, Polo S, Almouzni G. Variations sur le thème du code histone. Med Sci (Paris) 2005; 21 : 384–9. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.